Compare SYK & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYK | CI |
|---|---|---|
| Founded | 1941 | 1792 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.4B | 79.0B |
| IPO Year | 1994 | 2018 |
| Metric | SYK | CI |
|---|---|---|
| Price | $309.66 | $280.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 15 |
| Target Price | ★ $415.57 | $349.00 |
| AVG Volume (30 Days) | ★ 2.4M | 1.3M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | 1.12% | ★ 2.13% |
| EPS Growth | 8.25 | ★ 83.00 |
| EPS | 1.93 | ★ 6.26 |
| Revenue | $25,116,000,000.00 | ★ $274,900,000,000.00 |
| Revenue This Year | $9.80 | $5.91 |
| Revenue Next Year | $8.44 | $5.92 |
| P/E Ratio | $156.03 | ★ $45.48 |
| Revenue Growth | 11.16 | ★ 11.24 |
| 52 Week Low | $281.00 | $239.51 |
| 52 Week High | $404.87 | $338.89 |
| Indicator | SYK | CI |
|---|---|---|
| Relative Strength Index (RSI) | 50.83 | 44.83 |
| Support Level | $290.96 | $280.76 |
| Resistance Level | $319.17 | $293.09 |
| Average True Range (ATR) | 7.80 | 5.95 |
| MACD | 0.89 | -0.36 |
| Stochastic Oscillator | 74.97 | 36.75 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.